The company is appealing the determination, which keeps CYCU trading on Nasdaq during the review, while management says operations and strategic execution remain unaffected.
Cycurion, Inc. said it received a Nasdaq delisting determination after its common stock closed below the $1.00 minimum bid price for 31 consecutive business days from May 26, 2026 through July 9, 2026. The July 10, 2026 letter said the company was not in compliance with Nasdaq Listing Rule 5550(a)(1), and Nasdaq also determined Cycurion was ineligible for the usual 180-calendar day compliance period because it carried out a 1-for-30 reverse stock split on October 27, 2025, within the prior year. The company said it is appealing the decision, a step that allows its shares to remain listed and continue trading on Nasdaq while the Nasdaq Hearings Panel reviews the case. Cycurion cautioned there is no assurance the panel will grant continued listing or that it will regain compliance. The company said its board and management are not pursuing a reverse stock split at this time and are evaluating other options, while adding that the matter does not affect operations and citing an annual revenue run rate exceeding $28 million.